- Home
- RCUS vs CGAU Comparison
RCUS vs CGAU Comparison
Compare RCUS & CGAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- CGAU
- Stock Information
- Founded
- RCUS 2015
- CGAU 2002
- Country
- RCUS United States
- CGAU Canada
- Employees
- RCUS N/A
- CGAU N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- CGAU Precious Metals
- Sector
- RCUS Health Care
- CGAU Basic Materials
- Exchange
- RCUS Nasdaq
- CGAU Nasdaq
- Market Cap
- RCUS 2.4B
- CGAU 2.4B
- IPO Year
- RCUS 2018
- CGAU N/A
- Fundamental
- Price
- RCUS $19.94
- CGAU $11.77
- Analyst Decision
- RCUS Buy
- CGAU Buy
- Analyst Count
- RCUS 8
- CGAU 3
- Target Price
- RCUS $27.63
- CGAU $14.17
- AVG Volume (30 Days)
- RCUS 1.8M
- CGAU 1.6M
- Earning Date
- RCUS 10-28-2025
- CGAU 10-28-2025
- Dividend Yield
- RCUS N/A
- CGAU 1.69%
- EPS Growth
- RCUS N/A
- CGAU 236.39
- EPS
- RCUS N/A
- CGAU 1.60
- Revenue
- RCUS $240,000,000.00
- CGAU $1,285,392,000.00
- Revenue This Year
- RCUS N/A
- CGAU $9.10
- Revenue Next Year
- RCUS N/A
- CGAU $13.13
- P/E Ratio
- RCUS N/A
- CGAU $7.40
- Revenue Growth
- RCUS N/A
- CGAU 2.66
- 52 Week Low
- RCUS $6.50
- CGAU $5.41
- 52 Week High
- RCUS $22.11
- CGAU $12.80
- Technical
- Relative Strength Index (RSI)
- RCUS 64.34
- CGAU 54.26
- Support Level
- RCUS $19.33
- CGAU $11.51
- Resistance Level
- RCUS $20.99
- CGAU $12.56
- Average True Range (ATR)
- RCUS 1.17
- CGAU 0.49
- MACD
- RCUS -0.19
- CGAU -0.00
- Stochastic Oscillator
- RCUS 43.93
- CGAU 46.32
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About CGAU Centerra Gold Inc.
Centerra Gold Inc a gold mining and exploration company engaged in the operation, exploration, development, and acquisition of gold properties in Asia, North America, and other markets world-wide. The company reportable operating segments are Oksut; Mount; and Milligan Molybdenum. It derives maximum revenue from Oksut segment. Geographically, it operates in Turkey, United States, Canada and Other.